Tower Research Capital LLC (Trc) Acorda Therapeutics Inc Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.55 - $1.0 $3,402 - $6,186	6,186 Added 109.12%	11,855 $7,000
Q4 2022 Feb 10, 2023	SELL	$0.52 - $0.77 $4,967 - $7,355	-9,552 Reduced 62.76%	5,669 $4,000
Q3 2022 Nov 10, 2022	SELL	$0.29 - $0.53 $3,483 - $6,366	-12,013 Reduced 44.11%	15,221 $5,000
Q2 2022 Aug 15, 2022	BUY	$0.3 - $1.67 $7,996 - $44,513	26,655 Added 4603.63%	27,234 $13,000
Q1 2022 May 12, 2022	BUY	$1.61 - $2.5 $932 - $1,447	579 New	579 $1,000
Q4 2021 Feb 14, 2022	SELL	$2.3 - $4.71 $13 - $28	-6 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.79 $315 - $450	-94 Reduced 94.0%	6 $0
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.23 $361 - $523	100 New	100 $0

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.